ITGA6 and breast neoplasm: Since in breast tumors CD49f was considered a marker for distant metastasis and recurrence, CD49f+/CD44high/CD24low CTH cells represented an aggressive phenotype which is associated with an increased risk for disease recurrence with poor clinical outcomes [41].